The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Revenues | 1,448,685 |
| Employee expenses (excluding share-based compensation expense) | 309,600 |
| Share-based compensation expense | 13,850 |
| Other segment items | 1,028,812 |
| Depreciation and amortization | 22,335 |
| Interest expense | 665 |
| Income taxes | 24,465 |
| Net income (loss) | 48,958 |
| Depreciation and amortization | 22,335 |
| Share-based compensation expense | 13,850 |
| Provision for losses on accounts receivable | 4,581 |
| Change in deferred tax asset | 3,074 |
| Other | -1,075 |
| Accounts receivable | 8,553 |
| Inventories | 877 |
| Other current assets | 2,482 |
| Accounts payable | 16,398 |
| Accrued compensation | 618 |
| Other operating liabilities | 1,278 |
| Net cash provided by operating activities | 100,255 |
| Purchases of property and equipment | 19,545 |
| Payment for acquisitions | 13,416 |
| Other | 736 |
| Net cash used in investing activities | -32,225 |
| Proceeds from equity offering, net of underwriter fees | 29,039 |
| Repurchase (payments) of common stock-Common Class A | 29,039 |
| Payments of equity offering costs | 1,594 |
| Repurchase (payments) of common stock-Common Class B | 0 |
| Borrowings from notes payable | 0 |
| Repayment of notes payable | 497 |
| Borrowings from line of credit | 0 |
| Repayments of line of credit | 0 |
| Principal payments on finance lease obligations | 4,483 |
| Payments related to acquisitions | 2,509 |
| Contributions fromnon-controllinginterests | 1,970 |
| Distributions tonon-controllinginterests | 458 |
| Member distributions | 0 |
| Other | -500 |
| Net cash used in financing activities | -7,071 |
| Net change in cash and cash equivalents | 60,959 |
| Cash and cash equivalents, beginning of period | 4,660 |
| Cash and cash equivalents, end of period | 65,619 |
Guardian Pharmacy Services, Inc. (GRDN)
Guardian Pharmacy Services, Inc. (GRDN)